Background: No longitudinal data on hypothalamic-pituitary (HP) function are available in patients who had received cranial radiation therapy (CRT) for primary extrasellar brain tumors (PBT). Purpose: To investigate the effects of CRT on HP function in adults with PBT. Patients and methods: Twenty-six adults irradiated for PBT and six CRT naive controls were studied. CRT was delivered with 6 MV X-ray by a linear accelerator (2 Gy fraction schedule). Gross Tumor Volume (GTV) excluded the HP region that was contoured on the planning CT. Median dose to the HP region was 41.8 Gy (IQR: 30.7-49.8). Results: All controls maintained normal HP function. Hypopituitarism developed in 38% of CRT patients (GH deficiency 29%, ACTH 22%, TSH 14%, gonadotropin 4%, no abnormal prolactin level or diabetes insipidus). All HP failures occurred within 32 months after CRT. Conclusions: Adults undergoing CRT for PBT are at increased risk for HP dysfunction within 3 years from CRT. Endocrine surveillance is recommended also in adults patients exposed to CRT for primary brain tumors distant from HP region. © 2011 Elsevier Ireland Ltd All rights reserved. Radiotherapy and Oncology.

Time course of hypothalamic-pituitary deficiency in adults receiving cranial radiotherapy for primary extrasellar brain tumors

Marco, Losa;Michele, Reni
2011-01-01

Abstract

Background: No longitudinal data on hypothalamic-pituitary (HP) function are available in patients who had received cranial radiation therapy (CRT) for primary extrasellar brain tumors (PBT). Purpose: To investigate the effects of CRT on HP function in adults with PBT. Patients and methods: Twenty-six adults irradiated for PBT and six CRT naive controls were studied. CRT was delivered with 6 MV X-ray by a linear accelerator (2 Gy fraction schedule). Gross Tumor Volume (GTV) excluded the HP region that was contoured on the planning CT. Median dose to the HP region was 41.8 Gy (IQR: 30.7-49.8). Results: All controls maintained normal HP function. Hypopituitarism developed in 38% of CRT patients (GH deficiency 29%, ACTH 22%, TSH 14%, gonadotropin 4%, no abnormal prolactin level or diabetes insipidus). All HP failures occurred within 32 months after CRT. Conclusions: Adults undergoing CRT for PBT are at increased risk for HP dysfunction within 3 years from CRT. Endocrine surveillance is recommended also in adults patients exposed to CRT for primary brain tumors distant from HP region. © 2011 Elsevier Ireland Ltd All rights reserved. Radiotherapy and Oncology.
2011
Brain tumors; Cranial radiotherapy; Growth hormone deficiency; Hypopituitarism; Adrenocorticotropic Hormone; Aged; Brain Neoplasms; Case-Control Studies; Chi-Square Distribution; Cranial Irradiation; Dose-Response Relationship, Radiation; Female; Gonadotropins; Human Growth Hormone; Humans; Hypopituitarism; Hypothalamo-Hypophyseal System; Male; Middle Aged; Proportional Hazards Models; Radiotherapy Dosage; Statistics, Nonparametric; Thyrotropin; Time Factors; Tomography, X-Ray Computed; Hematology; Oncology; Radiology, Nuclear Medicine and Imaging
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/86875
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 35
  • ???jsp.display-item.citation.isi??? 31
social impact